RT @ECMOdaily: @slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest r…
RT @ECMOdaily: @slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest r…
RT @ECMOdaily: @slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest r…
RT @ECMOdaily: @slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest r…
RT @ECMOdaily: @slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest r…
@slthomps12 @ELSOOrg @FOAMecmo @abribriesco43 @ECMOprincess @asaiojournal @kmkempmd #ECLS in #Trauma Data from the largest registry of critically ill trauma patients receiving ECLS support demonstrates reasonable survival. With growing experience & imp
“With growing experience and improved safety profile, trauma should not be considered a contraindication for #ECLS.” https://t.co/7l7wYfiEmi https://t.co/fVFSj2DaaN
Indications and outcomes of extracorporeal life support in... : Journal of Trauma and Acute Care Surgery https://t.co/RorZpvLHHf
RT @jswol: @UzerSKhan #EASTjc Welcome to the second day of our #EASTjc due to ECLS in Trauma and the newest publication from #ELSORegistry…
RT @jswol: @UzerSKhan #EASTjc Welcome to the second day of our #EASTjc due to ECLS in Trauma and the newest publication from #ELSORegistry…
RT @jswol: @UzerSKhan #EASTjc Welcome to the second day of our #EASTjc due to ECLS in Trauma and the newest publication from #ELSORegistry…
@UzerSKhan #EASTjc Welcome to the second day of our #EASTjc due to ECLS in Trauma and the newest publication from #ELSORegistry #ELSOorg I appreciate you questions to https://t.co/gzw7smXjwL Indications and outcomes of extracorporeal life support in trauma
RT @UzerSKhan: Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l…
RT @traumamd1: @jswol is in Nuremberg, Germany to answer your questions. Thank you for being part of #EASTjc. No 1 indication is ARDS in tr…
RT @UzerSKhan: Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l…
RT @UzerSKhan: Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l…
RT @traumamd1: @jswol is in Nuremberg, Germany to answer your questions. Thank you for being part of #EASTjc. No 1 indication is ARDS in tr…
RT @traumamd1: @jswol is in Nuremberg, Germany to answer your questions. Thank you for being part of #EASTjc. No 1 indication is ARDS in tr…
RT @UzerSKhan: Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l…
RT @UzerSKhan: Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l…
@jswol is in Nuremberg, Germany to answer your questions. Thank you for being part of #EASTjc. No 1 indication is ARDS in trauma does the table 3- Vent characteristics support that? @UzerSKhan @DissanaikeMD @richmondcrew6 @ATompeck @aaerasmo https://t
Welcome to the July edition of our #EASTjc! Thank you to @jswol for joining us today to talk about her paper https://t.co/l9ozJEYxlM and thank you to my co-moderators @traumamd1 and @clramirez_md!
Getting more and more common https://t.co/7KekDzccLQ
Looking forward to a great conversation. https://t.co/thKloUScJF
RT @jswol: Twitter #EAST journal club #EASTjc with @jswol and your moderator, @UzerSKhan will be July 11-12. We'll be talking about ECMO…
RT @jswol: Twitter #EAST journal club #EASTjc with @jswol and your moderator, @UzerSKhan will be July 11-12. We'll be talking about ECMO…
RT @jswol: Twitter #EAST journal club #EASTjc with @jswol and your moderator, @UzerSKhan will be July 11-12. We'll be talking about ECMO…
RT @jswol: Twitter #EAST journal club #EASTjc with @jswol and your moderator, @UzerSKhan will be July 11-12. We'll be talking about ECMO…
Twitter #EAST journal club #EASTjc with @jswol and your moderator, @UzerSKhan will be July 11-12. We'll be talking about ECMO in trauma: https://t.co/hOLxd9Lfsz See you then! Open access for paper of the month https://t.co/hOLxd9Lfsz
Interesting - especially with ARI becoming a @NoS_MTC. Also one of the complications noted (no surprise) being bleeding and the experience of reduced or no anticoagulants in ARI ICU. @AberdeenICUEdu @AberdeenICUQI #AberdeenECMO #ECMO https://t.co/LdyAXHB3M
Food for thought? @sithlord2004 @trauma_jm @markcfitz https://t.co/JPVe4Dq8jh
👏🏽👏🏽👏🏽 https://t.co/x4EtNoYPIV
RT @EASTjournalclub: It is my pleasure to announce the next @EAST_TRAUMA Twitter journal club will be on July 11-12! We will be joined by…
RT to remind myself to read this tonight :D https://t.co/UWSLMFLuu7
Indications & outcomes of extracorporeal life support in #TraumaPatients @jswol et al https://t.co/lFMmpSUSh6 @JTraumAcuteSurg
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
Great work out of ELSO and David Zonies! @OHSUsurgery https://t.co/z208asasqK
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
RT @JTraumAcuteSurg: Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo…
Indications and outcomes of extracorporeal life support in trauma patients https://t.co/pGBtwZUEkP https://t.co/VNb9Uo792s
Bottom Line: ECLS helps patients survive ARDS. The etiology (trauma rather than medical) doesn't really matter. Bad lungs are bad lungs. #FOAMed https://t.co/C7R3STt9fu
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
RT @criticalcareuk: #ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be…
#ECMO in Trauma, @ELSOOrg data 89% VV, 11% VA of which 4% ECPR - survival range 25-70% - a bridge that can no longer be ignored #Trauma - meanwhile in UK still debating role of ECLS in medical cardiac arrest, absurd. https://t.co/bBJ2JxoQwC
Indications and outcomes of extracorporeal life support in... : Journal of Trauma and Acute Care Surgery https://t.co/H3jkx1zKfX
Trauma is not necessarily a contraindication to #ECMO Indications and outcomes of extracorporeal life support in trauma patients from @JTraumAcuteSurg https://t.co/CXAP1MGhHa?